These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12570813)

  • 1. Neuropeptides as autocrine growth factors in cancer cells.
    Moody TW; Chan D; Fahrenkrug J; Jensen RT
    Curr Pharm Des; 2003; 9(6):495-509. PubMed ID: 12570813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide G Protein-Coupled Receptors as Oncotargets.
    Moody TW; Ramos-Alvarez I; Jensen RT
    Front Endocrinol (Lausanne); 2018; 9():345. PubMed ID: 30008698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of neuropeptide analogues on calcium flux and proliferation in lung cancer cell lines.
    Bunn PA; Chan D; Stewart J; Gera L; Tolley R; Jewett P; Tagawa M; Alford C; Mochzuki T; Yanaihara N
    Cancer Res; 1994 Jul; 54(13):3602-10. PubMed ID: 7516822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth factor and peptide receptors in small cell lung cancer.
    Moody TW; Cuttitta F
    Life Sci; 1993; 52(14):1161-73. PubMed ID: 8383784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The release of bombesin-like peptides from small cell lung cancer cells.
    Moody TW; Korman LY
    Ann N Y Acad Sci; 1988; 547():351-9. PubMed ID: 2853597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide hormones and lung cancer.
    Moody TW
    Panminerva Med; 2006 Mar; 48(1):19-26. PubMed ID: 16633328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of neuropeptide-stimulated tyrosine phosphorylation and tyrosine kinase activity stimulates apoptosis in small cell lung cancer cells.
    Tallett A; Chilvers ER; Hannah S; Dransfield I; Lawson MF; Haslett C; Sethi T
    Cancer Res; 1996 Sep; 56(18):4255-63. PubMed ID: 8797601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ghrelin and cortistatin in lung cancer: expression of peptides and related receptors in human primary tumors and in vitro effect on the H345 small cell carcinoma cell line.
    Cassoni P; Allia E; Marrocco T; Ghè C; Ghigo E; Muccioli G; Papotti M
    J Endocrinol Invest; 2006 Oct; 29(9):781-90. PubMed ID: 17114908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide receptors as cancer drug targets.
    Moody TW
    Ann N Y Acad Sci; 2019 Nov; 1455(1):141-148. PubMed ID: 31074514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion.
    Song P; Sekhon HS; Lu A; Arredondo J; Sauer D; Gravett C; Mark GP; Grando SA; Spindel ER
    Cancer Res; 2007 Apr; 67(8):3936-44. PubMed ID: 17440109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine and paracrine signaling through neuropeptide receptors in human cancer.
    Heasley LE
    Oncogene; 2001 Mar; 20(13):1563-9. PubMed ID: 11313903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broad spectrum neuropeptide antagonists inhibit the growth of small cell lung cancer in vivo.
    Langdon S; Sethi T; Ritchie A; Muir M; Smyth J; Rozengurt E
    Cancer Res; 1992 Aug; 52(16):4554-7. PubMed ID: 1379515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
    Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
    Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin inhibits the secretion of bombesin-like peptides from small cell lung cancer cells.
    Kee KA; Finan TM; Korman LY; Moody TW
    Peptides; 1988; 9 Suppl 1():257-61. PubMed ID: 2908812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth of small cell lung cancer cells: stimulation by multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivo.
    Sethi T; Langdon S; Smyth J; Rozengurt E
    Cancer Res; 1992 May; 52(9 Suppl):2737s-2742s. PubMed ID: 1314136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
    Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
    Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SR48692 is a neurotensin receptor antagonist which inhibits the growth of small cell lung cancer cells.
    Moody TW; Chiles J; Casibang M; Moody E; Chan D; Davis TP
    Peptides; 2001 Jan; 22(1):109-15. PubMed ID: 11179604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents.
    Chan DC; Gera L; Stewart JM; Helfrich B; Zhao TL; Feng WY; Chan KK; Covey JM; Bunn PA
    Clin Cancer Res; 2002 May; 8(5):1280-7. PubMed ID: 12006549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of RT-PCR to detect co-expression of neuropeptides and their receptors in lung cancer.
    Ocejo-Garcia M; Ahmed SI; Coulson JM; Woll PJ
    Lung Cancer; 2001 Jul; 33(1):1-9. PubMed ID: 11429190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotensin may function as a regulatory peptide in small cell lung cancer.
    Davis TP; Crowell S; McInturff B; Louis R; Gillespie T
    Peptides; 1991; 12(1):17-23. PubMed ID: 1646999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.